Form EFFECT Eikon Therapeutics, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 30, 2026 4:30 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Man Group PLC : Form 8.3 - Gamma Communications Plc
- NTT DATA Business Solutions launches "Elevate", its Agentic AI-powered delivery framework, to help accelerate SAP transformations
- Toobit Launches SmartK for Futures Market Analysis
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share